The overall goal of this project is to understand how endothelin receptor B (Ednrb) regulates gastrointestinal motor patterns through smooth muscle and neuronal pathways. Signaling through endothelin receptor B (Ednrb) influences motility in the esophagus, stomach, small intestine, and colon. Mutation of the gene that encodes for Ednrb can cause Hirschsprung (HSCR) disease where enteric ganglion cells fail to develop in the distal colon. Our preliminary studies indicate that ENS structure, ENS activity, and Ednrb regulation of smooth muscle are altered in the proximal small intestine in a Hirschsprung mouse model, EdnrbtmlYwa, even in mice that appear normal and do not develop aganglionic megacolon. We hypothesize that Ednrb mutation alters regulation of motility even in the absence of aganglionic megacolon. Results from this proposal could have potential implicationsfor HSCR patients and for other patient populations that suffer from gastroesophageal reflux, irritable bowel syndrome, and constipation.
Three specific aims are proposed:
Aim 1 will compare the structure and function of the ENS in the small intestine between homozygote, heterozygote, and wildtype Ednrb mouse littermates. Density of the ENS in the proximal small intestine will be compared between by analyzing 3-dimensional confocal images. Electrical field studies of intestinal smooth muscle layers will evaluate myenteric neuronal activity.
Aim 2 will determine if Ednrb mutation affectsendothelin regulation of intestinal smooth muscle activity. Preliminary studies show a reduced smooth muscle response to Ednrb signaling with Ednrb mutation. Organ bath experiments will evaluate how Ednrb mutation affects endothelin regulation of smooth muscle.
Aim 3 investigate how Ednrb that is expressed by the enteric nervous system and intestinal smooth muscle interact in the regulation of intestinal smooth muscle activity. Preliminary studies indicate that Ednrb on smooth muscle cells and enteric neurons both alter intestinal smooth muscle activity. Neuronal Ednrb regulation of intestinal smooth muscle activity will be investigated by developing a transgenic mouse model to isolate Ednrb expression to the ENS.
This project seeks to identify new therapeutic targets for medical intervention for gastrointestinal motility disorders by understanding how endothelin receptor B (Ednrb) regulates gasrointestinal motlity. Knowledge of how Ednrb signaling alters gastrointestinal smooth muscle activity could lead to potential treatments for common disorders affecting 10-30% of the US population, such as reflux, constipaiton, and gastroparesis.
|Liñán-Rico, A; Wunderlich, J E; Enneking, J T et al. (2015) Neuropharmacology of purinergic receptors in human submucous plexus: Involvement of P2X?, P2X?, P2X? channels, P2Y and A? metabotropic receptors in neurotransmission. Neuropharmacology 95:83-99|
|Liñán-Rico, Andrómeda; Wunderlich, Jacqueline E; Grants, Iveta S et al. (2013) Purinergic autocrine regulation of mechanosensitivity and serotonin release in a human EC model: ATP-gated P2X3 channels in EC are downregulated in ulcerative colitis. Inflamm Bowel Dis 19:2366-79|